Clinical trial
Brain Imaging: Cocaine Effects & Medication Development - 5
NCT00000270 · New York State Psychiatric Institute, Other · Withdrawn
Key facts
| NCT number | NCT00000270 |
|---|---|
| Title | Brain Imaging: Cocaine Effects & Medication Development - 5 |
| Official title | Brain Imaging: Cocaine Effects & Medication Development |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Cocaine |
| Enrollment | 0 |
| Start date | Dec 30, 1995 |
| Primary completion | Dec 30, 1995 |
| Completion | Dec 30, 1995 |
| First posted | Sep 21, 1999 |
| Last update posted | Aug 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: